Adalimumab Biosimilar Comparable for Crohn's Disease

]]>(MedPage Today) -- ORLANDO -- A biosimilar of adalimumab (Humira) was comparable to the drug to treat Crohn's disease, a researcher said here.The biosimilar, BI 695501 (Boehringer Ingelheim) demonstrated non-inferiority in terms of efficacy compared...